FDA Device Center Must Take Bigger Risks, Director Says
The Food and Drug Administration's aversion to risk is hindering medical device innovation and investment, and the agency must get comfortable with allowing devices onto the market even with bigger safety...To view the full article, register now.
Already a subscriber? Click here to view full article